What's breaking now, across thousands of outlets.
(MedPage Today) -- Subcutaneous risankizumab (Skyrizi) induction therapy significantly improved clinical remission and endoscopic response rates in patients with moderately to severely active Crohn's disease, results from the phase III AFFIRM trial...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
This proceedings eBook, developed in partnership with GEN and Cincinnati Children’s Hospital Applied Gene and Cell Therapy Center, captures perspectives and lessons from The Cell Summit ’26 and…
A pastor and his wife have been arrested in South Africa after 200 people, some in chains, were found held at a suspected illegal rehabilitation centre in the north-eastern part of the country.
Prosecutors allege Moises Freire gave two students at FIT the opioid, saying it was cocaine, and raped one as she overdosed A man raped a student at New York ’s Fashion Institute of Technology (FIT)…
Norway’s Queen Mette-Marit has returned to public attention after undergoing major lung transplant surgery and taking a break from royal duties.
New research offers a new perspective on social anxiety, which is often viewed mainly as a source of distress.
